Based in Henley, England, YRCR provides advice and support, including full marketing authorisation applications, to a broad range of European, US and Japanese clients. The consideration will be satisfied through a combination of cash and shares. ICON has also entered into an employment agreement with the company's founder. Accounted for a purchase transaction, ICON expects the acquisition to be neutral to earnings in 2000.
ICON provides contract clinical research services to the pharmaceutical industry world-wide.
From these locations, the company is managing projects in over 30 countries on four continents. These statements involve risks and uncertainties that could cause actual results to differ materially including, without limitation, actual operating performance, the ability to maintain large client contracts or enter into new contracts, the ability to manage the opening of new offices, and the ability to maintain client relationships.